Neurobiology of depression in Parkinson's disease: Insights into epidemiology, molecular mechanisms and treatment strategies

MH Ahmad, MA Rizvi, M Ali, AC Mondal - Ageing research reviews, 2023 - Elsevier
Parkinson's disease (PD) is characterized mainly by motor dysfunctions due to the
progressive loss of dopaminergic neurons. However, PD patients experience a multitude of …

Neuroinflammation in Parkinson's disease: from gene to clinic: a systematic review

C Castillo-Rangel, G Marin… - International Journal of …, 2023 - mdpi.com
Parkinson's disease is a neurodegenerative disease whose progression and clinical
characteristics have a close bidirectional and multilevel relationship with the process of …

Recent advances towards overcoming the blood–brain barrier

A Ali, MS Arshad, MA Khan, MW Chang, Z Ahmad - Drug Discovery Today, 2023 - Elsevier
The blood–brain barrier (BBB) is a protective element of the neurovascular unit (NVU)
surrounded by astrocytes, pericytes, extracellular matrix, and the tight junctional complex …

The pathobiological basis of depression in Parkinson disease: challenges and outlooks

KA Jellinger - Journal of neural transmission, 2022 - Springer
Depression, with an estimated prevalence of about 40% is a most common neuropsychiatric
disorder in Parkinson disease (PD), with a negative impact on quality of life, cognitive …

[HTML][HTML] Noradrenergic neuromodulation in ageing and disease

F Krohn, E Lancini, M Ludwig, M Leiman… - Neuroscience & …, 2023 - Elsevier
The locus coeruleus (LC) is a small brainstem structure located in the lower pons and is the
main source of noradrenaline (NA) in the brain. Via its phasic and tonic firing, it modulates …

Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson's disease: interplay between nuclear factor-kappa β and …

DM Hassan, AH El-Kamel, EA Allam, BA Bakr… - Drug Delivery and …, 2024 - Springer
Parkinson's disease (PD) is the second most common progressive neurodegenerative
disorder associated with increased oxidative stress, the underlying vital process contributing …

Psychometrics and diagnostics of the Italian version of the Beck Depression Inventory-II (BDI-II) in Parkinson's disease

G Maggi, A D'Iorio, EN Aiello, B Poletti, N Ticozzi… - Neurological …, 2023 - Springer
Introduction Depression is one of the most disabling neuropsychiatric manifestations of
Parkinson's disease (PD) and requires proper screening and diagnosis because it affects …

[HTML][HTML] The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson's disease: a double-blind …

S Mehrabani, F Khorvash, Z Heidari… - Journal of Functional …, 2023 - Elsevier
Researches show that the pathogenesis of Parkinson's disease (PD) is influenced by
oxidative stress. This randomized controlled trial investigated the effect of 12 weeks of …

[HTML][HTML] Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models

S Hayley, F Vahid-Ansari, H Sun, PR Albert - Neurobiology of Disease, 2023 - Elsevier
Parkinson's disease (PD) is a complex illness with a constellation of environmental insults
and genetic vulnerabilities being implicated. Strikingly, many studies only focus on the …

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson's Disease: An Updated Review

E Angelopoulou, E Stanitsa, CC Karpodini, A Bougea… - Medicina, 2023 - mdpi.com
Depression represents one of the most common non-motor disorders in Parkinson's disease
(PD) and it has been related to worse life quality, higher levels of disability, and cognitive …